Page last updated: 2024-10-26

etidronate and Aldosteronism with Hyperplasia of the Adrenal Cortex

etidronate has been researched along with Aldosteronism with Hyperplasia of the Adrenal Cortex in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research Excerpts

ExcerptRelevanceReference
"Radiographic changes of osteitis fibrosa cystica developed in 1 child and bone biopsy in 2 children showed defective osteoid mineralisation."1.26Diphosphonate therapy in nephrocalcinosis. ( McCredie, DA; Powell, HR; Rotenberg, E, 1976)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCredie, DA1
Powell, HR1
Rotenberg, E1

Other Studies

1 other study available for etidronate and Aldosteronism with Hyperplasia of the Adrenal Cortex

ArticleYear
Diphosphonate therapy in nephrocalcinosis.
    British journal of urology, 1976, Volume: 48, Issue:2

    Topics: Bartter Syndrome; Body Height; Bone and Bones; Calcium; Child; Diet; Drug Evaluation; Etidronic Acid

1976